TriSalus Life Sciences
Pre-clinicalTriSalus Life Sciences® seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies, and our investigational immunotherapy.
Founded
2015
Focus
Drug Delivery
About
TriSalus Life Sciences® seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies, and our investigational immunotherapy.
Funding History
2Total raised: $60M
Series B$40MUndisclosedSep 15, 2022
Series A$20MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationWestminster, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile